RonanRx Inc. YC Başvurusu

Summer 2026Active

San Francisco

RonanRx Inc., Healthcare şirketi olarak Summer 2026 grubunda Y Combinator'dan geçti. Aşağıda: şirketin ne yaptığı, kimin kurduğu ve gerçek YC formunda yeniden yapılandırılmış YC başvurusu.

YC grubu: Summer 2026
Sektör: Healthcare
Konum: San Francisco
Ekip büyüklüğü: 5
Durum: Active
Lansmanı Yapıldı: 2026

Kurucular

Lloyd ArmbrustFounder/CEO
Emily ColmanFounder

RonanRx Inc. ne yapar

RonanRX is a full-stack pharmaceutical company, starting with personalized peptides and GLP-1s. In our first 10 weeks, we went from having no pharmacy to being licensed in 33 states. Since launch, we’ve grown 50% week over week. We manufacture the medications ourselves, sell directly to patients, and eliminate the layers of middlemen that make prescription drugs more expensive. What makes this possible is AI. Traditional pharmaceutical companies are built to manufacture one drug for millions of people. RonanRX is purpose-built to personalize treatment for each patient: different biology, different response, different dose. Patients come directly to RonanRX or through doctors using our platform. Every patient completes our medical intake, meets with a licensed doctor through our telehealth platform, and receives a personalized prescription when appropriate. From there, we manufacture the medication ourselves and deliver it directly to the patient. Labs, wearables, medical history, treatment response, and other health data feed back into the platform so doctors can continuously refine treatment over time. Before AI, doing this for every patient at scale was impossible. We didn't invent the demand we are seeing. 80 Million people are on a GLP-1 and millions more are using Peptides. We're building a better way to manufacture, personalize, prescribe, and deliver them. Our founders have built and exited multiple companies, raised more than $100M, built a $50M U.S. medical manufacturing business, and spent years developing peptide therapeutics at companies including Eli Lilly and AbbVie. We’re just getting started with peptides and GLP-1s. Next comes hormone therapy and the rest of personalized medicine.

RonanRx Inc.'in YC başvurusu, yeniden yapılandırılmış

Y Combinator başvurusu

RonanRx Inc., Summer 2026 dönemi. Gerçek form soruları, herkese açık verilerden yanıtlandı.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

RonanRx Inc.

Describe what your company does in 50 characters or less.

Personalized peptides & GLP-1s, direct to patient.

What is your company going to make? Please describe your product and what it does or will do.

We are building RonanRX, a pharmaceutical company focused on personalized peptides and GLP-1 medications. Patients complete an online medical intake, meet with a licensed doctor through our telehealth platform, and receive a tailored prescription. We manufacture the drugs ourselves and ship directly to the patient, taking care of every step from medical consultation to delivery. We use AI to make it possible to personalize treatments at scale and close the feedback loop between patient data and ongoing care.

Where do you live now, and where would the company be based after YC?

We are based in San Francisco, CA and will continue to be based there after YC.

Explain your decision regarding location.

San Francisco is our home and it's where our team, facility, and network are already set up. It's also the best place for health tech and for building a telehealth company quickly.

Tam başvuruda 21 ek cevap

Founders, Progress, Idea, Equity, Curious, Batch Preference tam sürümde. YC Insights'ta, diğer her YC grubu yanında açmak için ücretsiz bir hesap oluşturun.

Tüm başvuruyu gör

Sıkça Sorulan Sorular

Bu, RonanRx Inc. şirketinin gerçek YC başvurusu mu?

Hayır. Y Combinator gönderilen başvuruları gizli tutar. Bu bir yeniden yapılandırmadır: gerçek YC form soruları, RonanRx Inc.'in kamuya açık verilerinden (lansman notları, kurucu geçmişleri, ürün açıklaması) yanıtlanmıştır. RonanRx Inc. gibi bir şirketin YC'ye kendisini nasıl sunacağını gösterir, gönderdikleri metni değil.